UBS raised the firm’s price target on C.H. Robinson (CHRW) to $133 from $129 and keeps a Buy rating on the shares. The company’s Q2 upside was driven by cost control and strong gross margins, the analyst tells investors in a research note. The firm says C.H. Robinson’s continued progress increases visibility on it achieving its targets.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHRW:
- CH Robinson: Strong Earnings and Technological Advances Amid Trade Policy Uncertainties Justify Hold Rating
- C.H. Robinson price target raised to $95 from $90 at Barclays
- C.H. Robinson Reports Strong Q2 2025 Performance
- C.H. Robinson reports Q2 adjusted EPS $1.29, consensus $1.16
- CHRW Upcoming Earnings Report: What to Expect?